Page last updated: 2024-11-05

thalidomide and Tonsillitis

thalidomide has been researched along with Tonsillitis in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Tonsillitis: Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Banday, AZ1
Joshi, V1
Arora, K1
Sadanand, R1
Basu, S1
Pilania, RK1
Jindal, AK1
Vignesh, P1
Gupta, A1
Sharma, S1
Dhaliwal, M1
Rawat, A1
Singh, S1
Suri, D1
Loyal, J1
Flores, S1
Alikhan, A1

Reviews

1 review available for thalidomide and Tonsillitis

ArticleYear
Challenges in the diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome in developing countries-A decade of experience from North India.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Antipyretics; Antiviral Agents; Child; Colchicine; Developing Countries; Fever; Humans; Lymphadeniti

2022

Other Studies

1 other study available for thalidomide and Tonsillitis

ArticleYear
Resolution of psoriasis after tonsillectomy.
    Dermatology online journal, 2017, 02-16, Volume: 23, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Facial Dermatoses; Female; Glucocorticoids; Humans; Pharyng

2017